BioSpace News Archive

Genetown

Surface Oncology to Present Non-clinical Data for SRF388 and SRF114 at the Society for Immunotherapy of Cancer 2022 Annual Meeting

Surface Oncology today announced the presentation of two posters at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting in Boston.

November 7, 2022
·
4 min read
Genetown

EyePoint Pharmaceuticals Announces Participation at Upcoming November 2022 Investor Conferences

EyePoint Pharmaceuticals, Inc. announced that EyePoint Pharmaceuticals will present at the following upcoming conferences.

November 7, 2022
·
1 min read
Pharm Country

Lisata Therapeutics Announces Participation in Upcoming Conferences in November 2022

Lisata Therapeutics, Inc. today announced that management will participate in the following events.

November 7, 2022
·
2 min read
Biotech Bay

Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors

Lyell Immunopharma, Inc. is presenting preclinical data at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on its product candidates and new genetic and epigenetic reprogramming technologies.

November 7, 2022
·
8 min read
Pharm Country

PDS Biotech Announces Presentation of Preliminary PDS0101 Efficacy, Safety, and Immunology Data at Society for Immunotherapy of Cancer (SITC 2022)

PDS Biotechnology Corporation announced upcoming poster presentations of clinical data from two Phase 2 clinical trials of PDS0101 at the 37th Annual Meeting for the Society for Immunotherapy of Cancer being held November 8-12, 2022 in Boston.

November 7, 2022
·
11 min read
Biotech Bay

Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Iovance Biotherapeutics, Inc. announced the publication of abstracts reporting clinical data and a trial in progress for Iovance tumor-infiltrating lymphocyte cell therapies for the upcoming Society for Immunotherapy of Cancer Annual Meeting, November 8-12, 2022, in Boston, MA and virtually.

November 7, 2022
·
8 min read
Lone Star Bio

Alaunos Therapeutics to Present Data Highlighting its hunTR™ TCR Discovery Platform at the Society for Immunotherapy of Cancer 2022 Annual Meeting

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company announced a poster presentation highlighting the potential of the Company’s human neoantigen T-cell receptor platform to expand its TCR Library.

November 7, 2022
·
5 min read
Bio NC

Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting

Humacyte, Inc. announced updated six-month results of the HAV in a baboon CABG model.

November 7, 2022
·
10 min read
Genetown

Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO

Candel Therapeutics, Inc. announced new clinical data will be presented in the upcoming 37th Annual Meeting of the Society for Immunotherapy of Cancer in Boston, MA and the 27th Annual Meeting of the Society for Neuro-Oncology in Tampa Bay, FL.

November 7, 2022
·
4 min read
Pharm Country

Geneos Therapeutics Announces Positive Clinical Data for Personalized Therapeutic Cancer Vaccines in Ongoing Liver Cancer Trial

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines, announced positive safety and efficacy data from the first 24 patients enrolled in GT-30.

November 7, 2022
·
9 min read